Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Brentuximab Vedotin Plus CHP in Frontline sALCL: Adjusted Estimates of Efficacy and Cost-Effectiveness Removing the Effects of Re-Treatment with Brentuximab Vedotin.
Pharmacoecon Open. 2022 Nov;6(6):881-892. doi: 10.1007/s41669-022-00349-z. Epub 2022 Sep 4.
Pharmacoecon Open. 2022.
PMID: 36057890
Free PMC article.
Cost-effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma.
Podkonjak T, Cranmer H, Scarisbrick J, McCarthy G, Lilley C, Cheng LI.
Podkonjak T, et al.
J Comp Eff Res. 2022 Feb;11(3):193-202. doi: 10.2217/cer-2021-0201. Epub 2021 Dec 9.
J Comp Eff Res. 2022.
PMID: 34879742
Free article.
Item in Clipboard
Real-world evidence use in assessments of cancer drugs by NICE.
Bullement A, Podkonjak T, Robinson MJ, Benson E, Selby R, Hatswell AJ, Shields GE.
Bullement A, et al. Among authors: podkonjak t.
Int J Technol Assess Health Care. 2020 Jul 10:1-7. doi: 10.1017/S0266462320000434. Online ahead of print.
Int J Technol Assess Health Care. 2020.
PMID: 32646531
Free article.
Item in Clipboard
An Attribution of Value Framework for Combination Treatments.
Briggs AH, Doyle-Connolly A, Schneider J, Podkonjak T, Taylor H, Roffe E, Low E, Davis S, Kaiser M, Hatswell AJ, Rabin N.
Briggs AH, et al. Among authors: podkonjak t.
Value Health. 2025 Jan;28(1):72-80. doi: 10.1016/j.jval.2024.08.012. Epub 2024 Oct 29.
Value Health. 2025.
PMID: 39481753
Free article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.